Viral Vector Purification via Cation Anion Exchange Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for purifying viral vector preparations often result in co-purification of DNA contaminants with the viral vector, leading to difficulties in separating DNA from the viral vector, especially when DNA forms aggregates or agglutinates that shield DNA from nucleic acid cleavage reactions.

Innovation Solution

A method involving the use of a cation exchanger to separate DNA impurities from the viral vector preparation, followed by treatment with an anion exchanger to bind and elute the viral vector, and finally subjecting the eluate to nucleic acid cleavage using a halotolerant nuclease to remove residual DNA.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If anion exchange is used to purify viral vectors, then viral vector binding is achieved, but DNA contaminants co-purify with the viral vector

Engineering Contradiction:
Improveviral vector recoveryVSAvoidDNA contamination
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The purification process is divided into two distinct chromatography steps: cation exchange to remove DNA contaminants and anion exchange to capture viral vectors. This segmentation allows each step to target specific components separately, preventing co-purification of DNA with viral vectors while maintaining high viral vector recovery

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Cation exchange is performed as a preliminary step before anion exchange to pre-remove DNA contaminants from the preparation. This preliminary action reduces the DNA load that would otherwise co-purify during the subsequent anion exchange step, improving final product purity

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If DNA forms aggregates or agglutinates, then DNA shielding from nucleic acid cleavage occurs, but separation difficulty increases

Engineering Contradiction:
ImproveDNA removal efficiencyVSAvoidseparation process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

Cation exchange is performed preliminarily to remove DNA and DNA-protein complexes before nucleic acid cleavage and anion exchange steps. This preliminary removal prevents DNA from forming protective aggregates during subsequent processing, ensuring DNA remains accessible for enzymatic degradation and eliminating the need for complex additional separation steps

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

Cation exchange acts as an intermediary step that facilitates the subsequent nucleic acid cleavage reaction by removing DNA in a form that is more accessible to nucleases. This intermediary action prevents the formation of shielded aggregates and simplifies the overall separation process

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively reduces DNA contamination in the viral vector preparation, improves the separation of viral vectors from DNA impurities, and enhances the efficiency of downstream filtration steps by reducing particle aggregation.

Implementation Method 1

passing a viral vector preparation through a cation exchanger

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 2

contacting flow-through from the cation exchanger with an anion exchanger that binds the viral vector

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 3

subjecting the eluate to nucleic acid cleavage using a halotolerant nuclease to remove residual DNA

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Enzyme

Data Source

PatentUS20250043308A1Purification Method of Viral Vectors
Publication Date: 2025.02.06 OXFORD BIOMEDICA (UK) LTD
  • US20250043308A1 patent drawing
  • US20250043308A1 patent drawing
  • US20250043308A1 patent drawing

AI summary

A method of purifying a viral vector preparation is described. The method comprises: passing a viral vector preparation through a cation exchange column, contacting flow-through from the cation exchange column with an anion exchanger that binds the viral vector, and eluting the bound viral vector from the anion 5 exchanger as a viral vector eluate.